Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest Gerd Binnig Stories

2013-03-27 12:28:59

Renowned industry experts to advise Definiens on clinical digital pathology market NEW YORK, March 27, 2013 /PRNewswire/ -- Definiens, the global leader of image and data analysis solutions for quantitative digital pathology, today announced it has appointed an Advisory Board comprising renowned industry experts and visionaries in digital pathology. As part of its market expansion strategy, Definiens established the new Board to provide independent advice on trends and opportunities...

2011-05-17 06:06:00

ZURICH, May 17, 2011 /PRNewswire/ -- IBM (NYSE: IBM) and ETH Zurich, a premiere European science and engineering university, hosted more than 600 guests from industry, academia and government, to open the Binnig and Rohrer Nanotechnology Center located on the campus of IBM Research - Zurich. The facility is the centerpiece of a 10-year strategic partnership in nanoscience between IBM and ETH Zurich where scientists will research novel nanoscale structures and devices to advance energy...

2010-06-11 05:30:00

SUNNYVALE, Calif., June 11 /PRNewswire-FirstCall/ -- Trimble (Nasdaq: TRMB) and Definiens, a Germany-based company specializing in image analysis solutions, today announced Trimble's acquisition of Definiens' Earth Sciences business assets and licensing of its software technology platform in an all-cash transaction. Financial terms were not disclosed. Definiens' Earth Sciences business includes eCognition® software, an advanced image analysis software suite for...

2009-12-03 11:49:00

MUNICH, Germany, PARSIPPANY, N.J. and ANDOVER, Mass., Dec. 3 /PRNewswire/ -- Definiens, the number one Enterprise Image Intelligence® company, and Visage Imaging® Inc., a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME) announced today that they have entered into a partnership to jointly develop and market advanced oncology solutions for the clinical and preclinical imaging domain. The partnership enables Definiens to utilize the...

2008-09-25 06:00:00

Clarient, Inc. (Nasdaq:CLRT) and Definiens, Inc. jointly announced today that they established a strategic partnership to employ a series of image analysis platforms for Clarient's in-house research and development, and Web-based customer portal PATHSiTE(SM). Under a five year collaborative agreement, Clarient and Definiens plan to develop and commercialize tools that will help to evaluate quantitative biomarkers that predict cancer treatment response to targeted therapies. Ken Bloom, MD,...